WELLINGTON MANAGEMENT GROUP LLP 13D/13G Filings for Therapeutics Acquisition Corp. (RACA)

WELLINGTON MANAGEMENT GROUP LLP 13D and 13G filings for Therapeutics Acquisition Corp.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-04
3:47 pm
Sale
2021-12-31 13G Therapeutics Acquisition Corp.
RACA
WELLINGTON MANAGEMENT GROUP LLP 0
0.000%
-877,832decrease
(Position Closed)
Filing
2021-02-04
10:27 am
Purchase
2020-12-31 13G Therapeutics Acquisition Corp.
RACA
WELLINGTON MANAGEMENT GROUP LLP 877,832
6.250%
877,832increase
(New Position)
Filing